The company has yet to release formal studies, but discussed two cases that illustrate the potential benefit of the methodology in improving patient treatment.
The institute will provide gene editing services and genetically modified cell lines to Analytical Biological Services.
The investment bank began coverage with an Outperform rating, noting that Horizon's recent acquisition of Dharmacon is highly complementary and synergistic.
Stakeholders increasingly highlight the need for better, more standardized tools to validate and compare liquid biopsy tests, and commercial firms have responded.
The deal covers Atum's custom vectors and Horizon's CHO Source biomanufacturing platform.
The worldwide distribution agreement expands Oxford's existing product and service portfolio, streamlining workflows for current customers, the company said.
The results begin to adress questions about whether the company's meticulous, but costly research services can actually impact patient outcomes.
Researchers used mosquito and monkey cell lines to propagate viral RNA in semen samples from a man infected with Zika while traveling in the Caribbean.
Cell line engineers from Horizon Genomics said a method to make or undo fusion oncogenes in cell lines could help create reference standards for cancer diagnostics.
Considering the widespread use of the cell line, these findings could have significant implications for the research community.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.
In Science this week: CRISPR-based approach for recording cellular events, and more.
A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.